Did Asset Allocation Fail Investors in 2008? (Morningstar) Video

Did Asset Allocation Fail Investors in 2008? (Morningstar)

This "Did Asset Allocation Fail Investors in 2008? (Morningstar)" video requires the latest version of Adobe Flash Player.
Download Flash

Get Flash

More From Investing

Please Rate

Send

Send to Your Friends

Use Your Email Software Or:

Send to: (enter email addresses, seperated by commas)

Your Name:

Your Email:

Your personal Message (optional):

Favorite

Favorites

This video has been added to 'My Favorites' in your studio.

This video has been removed from 'My Favorites' in your studio.

Loved this video? To add it to your faves, please Log in or Sign up now!

Flag

Flag this as Inappropriate

If you find this video to be inappropriate or offensive for any reason, please select a reason for reporting it from the dropdown menu below.

Reason

We are committed to reviewing each and every one of your submissions.

If you are the copyright owner of this video and believe it has been uploaded without your permission, please follow these instructions in order to submit a copyright infringement notice.

Videos Shared:

Member Since:

1/6/09

By: Morningstar

Watch the latest stock, mutual fund, and investing videos from Morningstar.com

Video Info:

How to videos/ Business videos/ Investing videos

Views:414 Rating:3 Comments:1

PIMCO subadvisor and asset allocation specialist Robert Arnott talks to Morningstar about how investors should...

PIMCO subadvisor and asset allocation specialist Robert Arnott talks to Morningstar about how investors should view the lessons of 2008.

Added:

1/6/09

Tags:

Asset Allocation etfs funds investing morningstar morningstar.com mutual options stocks

URL:

Embed: (More)

Comment on this Video

Your Name: Email (optional):

Are you human?

Comments
Add-ons
Links
Related
Transcript

By: Guest 1 month ago

Reply to this Comment

No text or picture Add-ons were added yet. How sad!

Featured Links:

Gao RFID Inc. Announces New Spin-off for Asset Tra

April 2008, Toronto ??? GAO RFID Inc., leading supplier of RFID Readers, Tags and RFID Solutions, has just launched a new spin off to address the skyrocketing demand from its customers for Asset Tracking Products and Solutions. GAO RFID continues to

http://www.articlesbase.com/press-releases-articles/gao-rfid-inc-announces-new-spinoff-for-asset-tracking-388106.html/9461024403

Where to Focus in a Tough 2009 for Energy (Morningstar)

Long-term opportunities in the energy industry - Morningstar analyst Eric Chenoweth weighs the short-term risks and long-term opportunities in the oil & gas industry.

Job Losses: How Bad Could It Get? (Morningstar)

Morningstar's Bob Johnson and Bill Bergman offer their take on December's numbers and what they tell us about our current place in the recession.

3 Bear Market Tips for Dividend Investors (Morningstar)

Bear Market Tips for Dividend Investors - Morningstar equities strategist Josh Peters on how to steer clear of cuts and maximize return potential in dividend stocks.

What the Stimulus Could Mean for You (Morningstar)

Stimulus Package Effects on Economy - Morningstar's Christine Benz and Bob Johnson discuss how the new plan may impact jobs, tax rebates, AMT, and unemployment relief.

2009 GDP: When the Worst Could Be Over - Part 1 (Morningstar)

Morningstar's Bob Johnson and Bill Bergman on what the GDP components are really telling us about the economy.

Unpacking the Unemployment Numbers (Morningstar)

Morningstar's perspectives on possible peak unemployment, temp employment indicators, and the alternative unemployment rate.

3 Staples Stocks at a Good Price (Morningstar)

Stocks at a Good Price - These firms merit shelf space in investors' portfolios, says Morningstar's Pat Dorsey.

Good Hands Take Big Write-Down (Morningstar)

2009 Insurance Industry Review - Morningstar stock analyst Jim Ryan gives his take on Allstate's results and outlook for life and P&C insurers.

Learn about the Big Pharma Blockbuster Watch - Morningstar

The Big Pharma Blockbuster Watch - Morningstar analyst Damien Conover outlines which new drugs and clinical trials hold the most potential for the industry.

Endgame for U.S. Banks (Morningstar)

As the crisis of confidence persists, Morningstar analyst Matt Warren examines the possible scenarios for the industry.

There is no transcript for this video yet – check back soon.